Article Details

Analysis: Novartis CEO may struggle to rally investors to Sandoz spin-off | Reuters

Retrieved on: 2022-08-26 09:57:08

Tags for this article:

Click the tags to see associated articles and topics

Analysis: Novartis CEO may struggle to rally investors to Sandoz spin-off | Reuters. View article details on HISWAI: https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-ceo-may-struggle-rally-investors-sandoz-spin-off-2022-08-26/

Excerpt

Novartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs business Sandoz, as weaker drug prices and jittery ...

Article found on: www.reuters.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up